#TogetherAgainstFlu – Bram Palache Video
The Northern Hemisphere #flu season is approaching!
So, when is the optimal time to offer flu vaccination to older adults, pregnant women, children and people living with chronic conditions? When is too early? And when is too late?
Bram Palache shares his thoughts with #TogetherAgainstFlu
More about #TogetherAgainstFlu: https://togetheragainstflu.com/
#TogetherAgainstFlu online campaign aims to keep raising awareness of the importance of flu vaccinations for healthcare workers, older adults and patients living with chronic conditions. We’re calling on health stakeholders, patient and advocacy organisations, opinion leaders and decision-makers to partner in sharing these campaign messages with their audiences. Our evidence-based messages aim to support their own advocacy for the prevention and control of seasonal influenza.
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.
Learn more
Related news and resources
The socio-economic value of adult immunisation programmes
Download this OHE report, commissioned by IFPMA, to learn more about the socio-economic value of adult vaccination programems on individual lives and societies at large.
Read more
Open letter from the biopharmaceutical industry to G20 Ministers in support of the advancement of the G20 Health Agenda
On 9 April 2024, IFPMA, Interfarma, and FIFARMA submitted an open letter to G20 Ministers in support of the advancement of the G20 Health Agenda. The letter is available for download in English, Portuguese, and Spanish.
Read moreThe socio-economic value of adult immunization (OHE)(Poster)
This study by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs, focusing on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in ten countries (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, United States). In a forthcoming publication, OHE will...
Read more